La lecture à portée de main
Découvre YouScribe en t'inscrivant gratuitement
Je m'inscrisDécouvre YouScribe en t'inscrivant gratuitement
Je m'inscrisDescription
Sujets
Informations
Publié par | friedrich-alexander-universitat_erlangen-nurnberg |
Publié le | 01 janvier 2006 |
Nombre de lectures | 48 |
Langue | Deutsch |
Poids de l'ouvrage | 4 Mo |
Extrait
Crown Ether-Metalloporphyrins as Ditopic Receptors
and
Pyropheophorbide-a Conjugates for the Photodynamic
Therapy of Tumors
Den Naturwissenschaftlichen Fakultäten
der Friedrich-Alexander-Universität Erlangen-Nürnberg
zur
Erlangung des Doktorgrades
2005
vorgelegt von
Matthias Helmreich
aus Bamberg Als Dissertation genehmigt von den Naturwissenschaftlichen Fakultäten der
Universität Erlangen-Nürnberg
Tag der mündlichen Prüfung: 14.10.2005
Vorsitzender der Promotionskommission: Prof. Dr. D.-P. Häder
Erstberichterstatter: Prof. Dr. A. Hirsch
Zweitberichterstatter: Prof. Dr. J. Gladysz
Drittberichterstatterin: Prof. Dr. B. Röder
Mein besonderer Dank gilt meinem Doktorvater Prof. Dr. Andreas Hirsch für die
gewährte Unterstützung, sowie das rege Interesse am Fortgang der Arbeit.
Außerdem möchte ich mich herzlichst bei meinem Co-Doktorvater und Betreuer Dr.
Norbert Jux für die Bereitstellung des interessanten Themengebietes, die
Bereitschaft zu fachlichen Diskussionen, sowie die umfassende Betreuung während
der gesamten Promotionszeit bedanken.
Die vorliegende Arbeit entstand in der Zeit vom April 2002 bis Juni 2005 am Institut
für Organische Chemie der Friedrich-Alexander-Universität Erlangen-NürnbergTable of Contents
1 Introduction............................................................................1
1.1 Porphyrin Systems and their Applications............................................... 1
1.2 Ditopic Receptors: Crown Ether-Porphyrins............................................ 3
1.3 Photodynamic Therapy ........................................................................... 8
1.3.1 The History of Photodynamic Therapy .................................................... 8
1.3.2 Mechanisms of the Photodynamic Therapy .......................................... 11
1.3.3 Photosensitizers in P 14
1.3.4 Photodynamic Therapy as a Therapy for other Diseases than
Cancer .................................................................................................. 17
1.4 Modular Carrier Systems ...................................................................... 20
1.5 Finding a Good Name for Porphyrin- and Chlorophyll-Compounds ...... 22
1.6 C -Fullerene as a building block .......................................................... 22 60
2 Aims..................................................................................... 25
3 Results and Discussion ..................................................... 27
3.1 Molecular Recognition – Crown Ether-Porphyrins and their
Coordination Properties ........................................................................ 27
3.1.1 Synthesis of the Parent Crown Ether-Porphyrin 26 and its Metal
Complexes ............................................................................................ 27
3.1.2 Kinetic Experiments – The Stabilizing Effect of the Crown.................... 30
3.1.3 Ditopic Receptors.................................................................................. 33
3.1.4 Synthesis of a Water Soluble System ................................................... 50
3.1.5 A Concept for the Synthesis of Oligomeric Porphyrin Crown Ether
Arrays – Construction of a Library of Building Blocks............................ 52
3.1.6 Rare Earth Metal Porphyrins................................................................. 56
3.2 The Photodynamic Therapy of Tumors – Construction of Multi-
Pyropheophorbide-a-Fullerene Assemblies .......................................... 59
3.2.1 Isolation of Pyropheophorbide-a 19 ...................................................... 59
3.2.2 Synthesis of Fullerene-Pyropheophorbide-a Conjugates Carrying
two Chromophoric Units........................................................................ 61
3.2.3 Increasing the Number of Chromophores – Introduction of a
Dendritic Unit......................................................................................... 66
3.2.4 Hexa-Substituted C -Systems as Multiplying Units.............................. 72 60
3.2.5 Synthesis of a Decapyropheophorbide-a-Antibody-Conjugate.............. 81
3.2.6 Increasing the Solubility in Polar Solvents - Pyropheophorbide-a
Derivatives with Polar Side Chains ....................................................... 88
3.2.7 Photophysical Investigations................................................................. 91
3.2.8 Biological Investigations: In Vitro Experiments with Photosensitizer-
Carrier-Systems; Uptake and Phototoxic Activity on Human
Lymphoid Cells...................................................................................... 97
4 Summary / Zusammenfassung........................................ 104
5 Experimental Part.............................................................. 115
5.1 Chemicals and Instrumentation........................................................... 115
5.2 Synthetic Procedures .......................................................................... 117
6 Crystal Structures..............................................................175
7 Publications........................................................................183
8 References..................................185
Index of Abbreviations
Ac acetyl
AFM atomic force microscopy
ALA 5-aminolevulinic acid
AMD age-related macular degeneration
BOC t-butyloxycarbonyl
Chl a chlorophyll-a
Chl b ll-b
DAPI 4´,6-diamidino-2-phenylindol dihydrochloride
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene
DCC N,N‘-dicyclohexylcarbodiimide
DMA 9,10-dimethylanthracene
DMAP 4-dimethylaminopyridine
DMF N,N‘-dimethylformamide
DMSO dimethylsulphoxide
ε extinction coefficient
EI-MS electron-impact mass spectrometry
eq equivalent
ESI electron spray ionisation
ET electron-transfer
FAB-MS fast atom bombardment mass spectrometry
FC flash column chromatography
FDA U.S. Food and Drug Administration
fs femto seconds
GPC gel permeation chromatography
HOBT 1-hydroxybenzotriazol
Hp hematoporphyrin
HpD hematoporphyrin derivative
HPLC high performance liquid chromatography
IR infra-red
ISC Intersystem crossing
LAH lithium aluminum hydride
LDL low density lipoproteins
MAb monoclonal antibody
MALDI-TOF matrix assisted laser desorption ionization – time of flight
NMR nuclear magnetic resonance
PBS phosphate buffered saline
PDT photodynamic therapy
Phe a Pheophytin-a
PIT photoimmunotherapy
ppm parts per million
ps pico seconds
Pyropheid-a pyropheophytin-a
RT room temperature
S electronic ground state 0
S first excited singlet-state 1
SEC size exclusion chromatography
T first excited triplet-state 1
TB trypan blue
TBDMS t-butyl dimethyl silyl
tBu t-butyl
TCB 1,2,4-trichlorobenzene
TFA trifluoroacetic acid
THF tetrahydrofuran
TLC thin layer chromatography
UV/Vis ultraviolet/visible
1O first excited singlet-state of dioxygen 2
3O triplet ground-state of dioxygen 2
quantum-yield of fluorescence Φ fl
triplet-state quantum yield Φ t
singlet-oxygen quantum yield Φ Δ
triplet-state lifetime τ tIntroduction
1 Introduction
1.1 Porphyrin Systems and their Applications
Why does the area of porphyrin chemistry attract so many scientists?
The answer will probably depend on the person you ask. Certainly a large number of
people interviewed will respond that porphyrin systems play a fundamental role in
many biological processes, e. g. photosynthesis (chlorophylls), oxygen transport
(hemoglobine) and oxygen storage (myoglobine), electron-transfer processes
(cytochromes), respiration, and so on.
There is no exact date for the beginning of the history of modern porphyrin research.
thIt was at the end of the 19 century when several groups started their investigations
on tetrapyrrols, mainly focused on naturally occurring pigments. In 1906, Richard
[1]WILLSTÄTTER published his first work about chlorophyll and was awarded the Nobel
Prize in chemistry in 1915 for his research on plant pigments and especially for his
work on chlorophyll.
[2]The macrocyclic structure of porphyrins was first proposed by KÜSTER in 1912. At
that time, nobody believed him, least of all Hans FISCHER, the father of modern
porphyrin chemistry. Hans FISCHER´S studies on blood and plant pigments, and his
[3, 4]synthesis of hemin were the next milestones in this area which were also awarded
the Nobel Prize in 1929.
After several decades of reduced interest, the next breakthrough was the
determination of the three-dimensional
structure of a bacterial photosynthetic
reaction center by Johann DE